147 related articles for article (PubMed ID: 9449530)
1. Correlation of the suppressive activity of a biological response modifier on the proliferation of peripheral blood mononuclear cells and the reduction of HIV titer.
Vila LM; Ríos-Olivares E; Vila S; Ríos Z; Rivera E; Robles R; Reyes JC; Castillo X
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):981-8. PubMed ID: 9449530
[TBL] [Abstract][Full Text] [Related]
2. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells.
Ríos Z; Ríos EO; Garcia MI; De Leon C; Guzman LM; Rodriguez W; Romero D; Hunter R
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S93-101. PubMed ID: 8574153
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
4. C3 binding glycoprotein from Cuscuta europea induced different cytokine profiles from human PBMC compared to other plant and bacterial immunomodulators.
Stanilova SA; Dobreva ZG; Slavov ES; Miteva LD
Int Immunopharmacol; 2005 Apr; 5(4):723-34. PubMed ID: 15710341
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral treatment induces a shift to type-2 cytokine responses in HIV-1 infected pregnant women.
Alonso R; Resino S; Bellón JM; Muñoz-Fernández MA
Eur Cytokine Netw; 2000 Dec; 11(4):647-53. PubMed ID: 11125309
[TBL] [Abstract][Full Text] [Related]
6. Survival and quality of life in HIV-positive patients treated with a polyantigenic immunomodulator.
Colón JI; Encarnación G; Ortiz Santini MR; Rodríguez Malavé MT; Santiago Delpín EA; Marchand AM
P R Health Sci J; 1997 Mar; 16(1):9-14. PubMed ID: 9160397
[TBL] [Abstract][Full Text] [Related]
7. Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users.
Ríos-Olivares E; Vilá LM; Reyes JC; Rodríguez JW; Colón JH; Pagán NO; Marrero A; Ríos-Orraca ZM; Boukli NM; Shapshak P; Robles RR
Drug Alcohol Depend; 2006 Dec; 85(3):236-43. PubMed ID: 16766138
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of cytokines and cyclosporine A on peripheral blood mononuclear cells from stable multiple sclerosis patients.
Guillen C; Prieto A; Alvarez-Cermeño JC; de la Piedra M; Gimeno A; Alvarez-Mon M
Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):527-49. PubMed ID: 10466078
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
10. Modulation by immunosuppressive agents of peripheral blood mononuclear cell responses to influenza A virus.
Gorse GJ; Kopp WC
J Lab Clin Med; 1987 Nov; 110(5):592-601. PubMed ID: 2444663
[TBL] [Abstract][Full Text] [Related]
11. Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Delaugerre C; Gourlain K; Tubiana R; Carcelain G; Marcelin AG; Chouquet C; Mouroux M; Duvivier C; Autran B; Costagliola D; Katlama C; Calvez V
Antivir Ther; 2003 Jun; 8(3):233-7. PubMed ID: 12924540
[TBL] [Abstract][Full Text] [Related]
12. Anti-fungal and cytokine producing activities of CD8 + T lymphocytes from HIV-1 infected individuals.
Colón MD; Toledo N; Valiente CL; Rodríguez N; Yano N; Mathews H; Yamamura Y
Bol Asoc Med P R; 1998; 90(1-3):21-6. PubMed ID: 9734153
[TBL] [Abstract][Full Text] [Related]
13. In vitro anti-HIV activity of oleanolic acid on infected human mononuclear cells.
Mengoni F; Lichtner M; Battinelli L; Marzi M; Mastroianni CM; Vullo V; Mazzanti G
Planta Med; 2002 Feb; 68(2):111-4. PubMed ID: 11859458
[TBL] [Abstract][Full Text] [Related]
14. Complex effects of interferon-alpha on the cytokine network in HIV infection--possible contribution to immunosuppression.
Stylianou E; Aukrust P; Müller F; Nordøy I; Frøland SS
Cytokine; 2001 Apr; 14(1):56-62. PubMed ID: 11298493
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-18 inhibits human immunodeficiency virus type 1 production in peripheral blood mononuclear cells.
Choi HJ; Dinarello CA; Shapiro L
J Infect Dis; 2001 Sep; 184(5):560-8. PubMed ID: 11494162
[TBL] [Abstract][Full Text] [Related]
16. In vitro immunomodulatory properties of tucaresol in HIV infection.
Clerici M; Cogliati M; Rizzardini G; Colombo F; Fossati S; Rhodes J; Bray D; Piconi S
Clin Immunol; 2000 Dec; 97(3):211-20. PubMed ID: 11112360
[TBL] [Abstract][Full Text] [Related]
17. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic killing of CD4+ T lymphocytes in HIV-1-infected PHA-stimulated PBL cultures is mediated by CD8+ LAK cells.
Wang L; Klimpel GR; Planas JM; Li H; Cloyd MW
Virology; 1998 Feb; 241(2):169-80. PubMed ID: 9499792
[TBL] [Abstract][Full Text] [Related]
19. Suppression of IL-6 level in human peripheral blood mononuclear cells stimulated with PHA/LPS after occupational exposure to chromium.
Katiyar S; Awasthi SK; Sahu RK
Sci Total Environ; 2008 Feb; 390(2-3):355-61. PubMed ID: 18031794
[TBL] [Abstract][Full Text] [Related]
20. Effect of limonin and nomilin on HIV-1 replication on infected human mononuclear cells.
Battinelli L; Mengoni F; Lichtner M; Mazzanti G; Saija A; Mastroianni CM; Vullo V
Planta Med; 2003 Oct; 69(10):910-3. PubMed ID: 14648393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
